Sigma-Aldrich — Investor Presentation (January 2013)
24 slides from Sigma-Aldrich's investor presentation, Jan 7, 2013
Slide 1: Sigma-Aldrich Corporation Investor Information January 2013
© 2012 Sigma-Aldrich Co. LLC. All rights reserved. Sigma-Aldrich Corporation January 2013 Investor Information
Slide 2: Cautionary Statements
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 2 Cautionary Statements • This presentation contains “forward-looking statements” regarding future sales, earnings, return on equity, cost savings, process improvements, free cash flow, share repurchases, capital expenditures, acquisitions and other
Slide 3: Sigma-Aldrich Overview: Delivering Value Through A Diversified Portfolio
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Sigma-Aldrich Overview 3 Delivering Value Through A Diversified Portfolio No customer comprises more than 2% of sales, no product more than 1% GLOBALLY BALANCED 40% United States and Canada 37% Europe, Middle East, Africa 23% Asia Pacific and Latin
Slide 4: History of the Company
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. History of the Company 37 Consecutive Years of Increasing EPS and Annual Dividends 4
Slide 5: Progression of Research vs SAFC
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 5 Progression of Research vs SAFC 90% 10% 1990 SAFC Research 2000 2010 2012 (YTD Q3) 85% 15% 72% 28% 68% 32% $0.5 Billion Sales 51,000 Products 4,100 Employees $1.1 Billion Sales 85,000 Products 6,200 Employees $2.3 Billion Sales 187,000 Products 7,
Slide 6: Business Units Driven by Product-Centric Lens
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Business Units Were Driven by Focus through a Product-Centric Lens – ABCM 6 2012 (YTD Q3) RESEARCH BUSINESS PRODUCT SEGMENTS Analytical Biology Chemistry Materials Science 68% 32% Note: percentages comprise approximate size of business to total comp
Slide 7: Driving Our Products into a Variety of Customer Classes
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. We Have Been Successful in Driving Our Products into a Variety of Customer Classes 7 Academic & Government Researchers Pharma & Biotech Discovery R&D Contract Research Organizations Dealers Clinical Laboratories Testing Labs Environmental Labs Indus
Slide 8: Enhancing Focus through a Customer-Centric Lens
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. APPLIED & INDUSTRIAL MARKETS COMMERCIAL MARKETS RESEARCH MARKETS Enhancing Focus through a Customer-Centric Lens 8 Academic & Government Researchers Pharma & Biotech Discovery R&D Contract Research Organizations Dealers Clinical Laboratories Testing
Slide 9: Creation of Customer-Focused Business Units
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Creation of Customer-Focused Business Units (BU) 9 Life Science BioReliance Hitech Diagnostics & Testing Labs Industrial Customers Pharmaceutical Academic & Government Dealers CURRENT Product-focused Organization RESEARCH ABCM (All Research Products
Slide 10: Business Units and Market Outlook
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Business Units and Market Outlook 10 RESEARCH APPLIED & INDUSTRIAL COMMERCIAL Sigma-Aldrich Mission Approx % of Total Sales Long-term Market Growth Outlook Broad supplier of products to the research laboratory 50% Low-to-mid single digits Supplier o
Slide 11: Research Markets
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 11 Description Reagents and consumables to life sciences and non-profit research organizations Manufacturing raw materials for commercial products Raw materials and solutions for testing in clinical and industrial applications Customer Market Segmen
Slide 12: Research Business Unit
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. RESEARCH Business Unit 12 Academic & Government Pharma & Biotech Discovery Dealers INITIATIVES CUSTOMER FOCUS • Continue to broaden product portfolio • Broaden/deepen our sales channels - eCommerce - Direct sales - Dealers • Work closer with major c
Slide 13: SAFC Commercial Markets
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 13 Description Reagents and consumables to life sciences and non-profit research organizations Manufacturing raw materials for commercial products Raw materials and solutions for testing in clinical and industrial applications Customer Market Segmen
Slide 14: Commercial Business Unit
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. COMMERCIAL Business Unit 14 Commercial Pharma & Biotech Electronics Services INITIATIVES CUSTOMER FOCUS • SAFC Top-100 Customer Strategy • Strengthen our leading position in cell culture media • Leverage our High Potency Compound (HPC) capacity • Br
Slide 15: Applied & Industrial Markets
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 15 Description Reagents and consumables to life sciences and non-profit research organizations Manufacturing raw materials for commercial products Raw materials and solutions for testing in clinical and industrial applications Customer Market Segmen
Slide 16: Applied & Industrial Business Unit
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. APPLIED & INDUSTRIAL Business Unit 16 Clinical Diagnostics Environmental Labs Industrial MOVING UP THE VALUE CHAIN CUSTOMER FOCUS COMPONENTS • Antibodies • Lab Essentials • Standards • Sample Prep • Oligos • Enzymes • LC/GC Columns • Solvents • Buff
Slide 17: 2012 Q3 YTD Organic Sales Growth
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 2012 Q3 YTD Organic Sales Growth 17 RESEARCH ABCM (All Research Products) SAFC (All Commercial Products) 2% COMMERCIAL APPLIED & INDUSTRIAL RESEARCH 1% 4% 5% TOTAL 3% Product-focused Organization Customer-focused Organization 5% TOTAL 3%
Slide 18: 2012 Guidance
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 2012 Guidance* Organic Sales Growth 18 Guidance for full-year adjusted EPS to be $3.80-3.90 * Outlook provided on 10/23/12 1st Half 2nd Half Full Year Research Low Single-digit Low Single-digit ~3% SAFC Mid Single-digit Mid-to-High Single-digit • Ch
Slide 19: Key Considerations for 2013
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Key Considerations for 2013 19 Positioning for continued growth in 2013 • Macro-economic environment • Pharma consolidation / site closures • Increased presence in Applied & Industrial Markets • SAFC Growth • Emerging Market Growth • Capital deploym
Slide 20: Proven Formula for Value Creation
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 22.4 22.5 22.9 23.2 24.3 25.7 2006 2011 1 ,7 9 8 2 ,0 3 9 2 ,2 0 1 2 ,1 4 8 2 ,2 7 1 2 ,5 0 5 2006 2011 Proven Formula for Value Creation +7% +340bps +10bps CAGR 20 20.9 20.6 22.8 22.8 21.5 21% 2006 2011 SALES GROWTH STRONG ROE GAAP MARGIN EXPANSION
Slide 21: Why Sigma-Aldrich?
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Why Sigma-Aldrich? 21 STRONG FINANCIAL POSITION PROVEN GLOBAL FRANCHISE - Well Diversified - Recognized Brands - Established Markets - Operational Excellence - Efficient Supply Chain Management FOCUSED STRATEGIES FOR GROWTH - Innovative Platforms -
Slide 22: Questions?
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. QUESTIONS? 22
Slide 23: Appendix: Reconciliation of GAAP to Non-GAAP Financial Measures
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 23 Appendix Reconciliation of GAAP to Non-GAAP Financial Measures
Slide 24: Reconciliation of Reported Sales Growth to Adjusted (Organic) Sales Growth
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Acquisition Adjusted Reported Currency Benefit (Organic) Research Chemicals (4)% (6)% 1% 1% SAFC 17% (5)% 17% 5% 2% (6)% 6% 2% Acquisition Adjusted Reported Currency Benefit (Organic) Research Chemicals (1)% (4)% 1% 2% SAFC 16% (4)% 15% 5% Total Cus